Laboratory Test Predictors for Major Bleeding in Elderly (≥80 Years) Patients With Nonvalvular Atrial Fibrillation Treated With Edoxaban 15 mg: Sub‐Analysis of the ELDERCARE‐AF Trial

BACKGROUND: We investigated the predictors related to major bleeding events during treatment with edoxaban 15 mg in patients aged ≥80 years with nonvalvular atrial fibrillation and high bleeding risk, for whom standard oral anticoagulants are inappropriate, focusing on standard laboratory tests rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikami, Takeshi, Hirabayashi, Kagami, Okawa, Keisuke, Betsuyaku, Tetsuo, Watanabe, Saori, Imamura, Yuki, Tanizawa, Kimihiko, Hayashi, Takuya, Akao, Masaharu, Yamashita, Takeshi, Okumura, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496443/
https://www.ncbi.nlm.nih.gov/pubmed/36056729
http://dx.doi.org/10.1161/JAHA.122.024970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496443/
https://www.ncbi.nlm.nih.gov/pubmed/36056729
http://dx.doi.org/10.1161/JAHA.122.024970

Ejemplares similares